Dirk H Busch

54PUBLICATIONS
291CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Life historiesInnate immunityHaematological tumoursElectrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Apr 10, 2026
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.

Linda Warmuth, Sarah Dötsch, Manuel Trebo

|Feb 24, 2026
Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory.

Sina Frischholz, Ev-Marie Schuster, Myriam Grotz

|Nov 25, 2025
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injury.

Julius C Fischer, Sascha Göttert, Maximilian Giller

|Nov 06, 2025
Epigenetically Controlled ZEB2 Expression Promotes the Cytotoxic Potential of CMV-Specific CD8<sup>+</sup> T Cells.

Varun Sasidharan Nair, Zheng Yu, Hosein Ahmadi

|Oct 03, 2025
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity.

Katharina Kocher, Felix Drost, Abel Mekonnen Tesfaye

|Sep 19, 2025
Next-generation T cell immunotherapies engineered with CRISPR base and prime editing: challenges and opportunities.

Karl Petri, Elvira D'Ippolito, Annette Künkele

Pageof 9